Whitehawk Therapeutics
WHWK3.8500.00% ( 0.000 )
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Whitehawk Therapeutics(WHWK) predict that the EBIT is -23.52 M (-54.57%), Beat estimate;the EPS is -0.32 (-117.5%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA--
0.00B100.00%
----
EBITExceed expectations
-0.02B54.57%
-0.03B65.71%
+0.00B11.14%
EPSMiss expectations
-0.32117.49%
-0.1233106.74%
-0.196710.75%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf